四川医学
四川醫學
사천의학
Sichuan Medical Journal
2015年
10期
1393-1396
,共4页
赵海明%赵正兰%罗玉明%胡珊珊
趙海明%趙正蘭%囉玉明%鬍珊珊
조해명%조정란%라옥명%호산산
托伐普坦%肝硬化%低钠血症%难治性腹水%老年人
託伐普坦%肝硬化%低鈉血癥%難治性腹水%老年人
탁벌보탄%간경화%저납혈증%난치성복수%노년인
tolvaptan%liver cirhosis%hyponatremia%refractory ascites%elderly patients
目的 观察托伐普坦片治疗老年肝硬化难治性腹水伴低钠血症患者的疗效及安全性. 方法 41例老年肝硬化难治性腹水伴低钠血症患者随机分为治疗组(21 例)与对照组(20例). 治疗组在常规治疗基础上加用托伐普坦片口服,而对照组加服安慰剂,共治疗14d. 观察两组治疗后临床效果及不良反应. 结果 治疗14d后,治疗组显效5例,有效14例,无效2例,有效率90. 48%;对照组显效2例,有效9例,无效9 例,总有效率为55. 00%,两组疗效比较差异有统计学意义(P<0. 05). 在本次试验中治疗组出现口渴3 例,口干2 例,未见其它不良反应. 结论 在老年难治性肝硬化腹水伴低钠血症患者中,短期口服托伐普坦,疗效显著,能进一步改善症状和体征,且无严重不良反应.
目的 觀察託伐普坦片治療老年肝硬化難治性腹水伴低鈉血癥患者的療效及安全性. 方法 41例老年肝硬化難治性腹水伴低鈉血癥患者隨機分為治療組(21 例)與對照組(20例). 治療組在常規治療基礎上加用託伐普坦片口服,而對照組加服安慰劑,共治療14d. 觀察兩組治療後臨床效果及不良反應. 結果 治療14d後,治療組顯效5例,有效14例,無效2例,有效率90. 48%;對照組顯效2例,有效9例,無效9 例,總有效率為55. 00%,兩組療效比較差異有統計學意義(P<0. 05). 在本次試驗中治療組齣現口渴3 例,口榦2 例,未見其它不良反應. 結論 在老年難治性肝硬化腹水伴低鈉血癥患者中,短期口服託伐普坦,療效顯著,能進一步改善癥狀和體徵,且無嚴重不良反應.
목적 관찰탁벌보탄편치료노년간경화난치성복수반저납혈증환자적료효급안전성. 방법 41례노년간경화난치성복수반저납혈증환자수궤분위치료조(21 례)여대조조(20례). 치료조재상규치료기출상가용탁벌보탄편구복,이대조조가복안위제,공치료14d. 관찰량조치료후림상효과급불량반응. 결과 치료14d후,치료조현효5례,유효14례,무효2례,유효솔90. 48%;대조조현효2례,유효9례,무효9 례,총유효솔위55. 00%,량조료효비교차이유통계학의의(P<0. 05). 재본차시험중치료조출현구갈3 례,구간2 례,미견기타불량반응. 결론 재노년난치성간경화복수반저납혈증환자중,단기구복탁벌보탄,료효현저,능진일보개선증상화체정,차무엄중불량반응.
Objective To investigate the short term clinical effect of tolvaptan on elderly patients with refractory ascites and hyponatremia due to liver cirrhosis. Methods 41 patients were divided into treatment group(21 cases) and control group(20 cases) . The former had taken tolvaptan orally besides conventional treatment for 5 days,meanwhile,the latter had taken placebo in-stead. The clinical effect and side effect were observed. Results After 14 day treatment, in treatment group, 5 cases were markedly effective,14 cases effective,2 cases ineffective,and the effective rate was 90. 48%. When comes to control group,the da-ta were 2,9,9,respectively,and the effective rate was 55%. The difference between two groups was significant(P<0. 05). As re-gards the side effects,only 3 patients felt thirsty,and 2 patients felt dry. Conclusion Taking tolvaptan orally for a short term was effective and had no severe side effect for elderly patients with refractory ascites and hyponatremia due to liver cirrhosis.